ES2176200T3 - Uso de la butirulea como agente anticonceptivo. - Google Patents

Uso de la butirulea como agente anticonceptivo.

Info

Publication number
ES2176200T3
ES2176200T3 ES93907234T ES93907234T ES2176200T3 ES 2176200 T3 ES2176200 T3 ES 2176200T3 ES 93907234 T ES93907234 T ES 93907234T ES 93907234 T ES93907234 T ES 93907234T ES 2176200 T3 ES2176200 T3 ES 2176200T3
Authority
ES
Spain
Prior art keywords
contraceptive
butirulea
bacterial
methods
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907234T
Other languages
English (en)
Inventor
Arye Rubinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albert Einstein College of Medicine
Original Assignee
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Einstein College of Medicine filed Critical Albert Einstein College of Medicine
Application granted granted Critical
Publication of ES2176200T3 publication Critical patent/ES2176200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Abstract

ESTA INVENCION SE REFIERE AL USO DE ALKILUREAS, TALES COMO BUTILUREA, ETILUREA, PROPILUREA O METILUREA, Y AL USO DE HIDROXIUREA COMO AGENTES ANTICONCEPTIVOS. LAS ALKILUREAS Y/O HIDROXIUREA SE PUEDEN UTILIZAR BIEN POR SI SOLAS O JUNTO CON UN PORTADOR FARMACEUTICAMENTE ACEPTABLE, Y SE PUEDEN UTILIZAR JUNTO CON LOS SISTEMAS ANTICONCEPTIVOS CONVENCIONALES PARA ABROGAR LA MOTILIDAD DEL ESPERMA.
ES93907234T 1992-03-06 1993-03-05 Uso de la butirulea como agente anticonceptivo. Expired - Lifetime ES2176200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/847,193 US5229423A (en) 1992-03-06 1992-03-06 Use of butylurea as a contraceptive agent

Publications (1)

Publication Number Publication Date
ES2176200T3 true ES2176200T3 (es) 2002-12-01

Family

ID=25300032

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907234T Expired - Lifetime ES2176200T3 (es) 1992-03-06 1993-03-05 Uso de la butirulea como agente anticonceptivo.

Country Status (10)

Country Link
US (2) US5229423A (es)
EP (1) EP0627914B1 (es)
JP (1) JPH08502239A (es)
AT (1) ATE218332T1 (es)
AU (1) AU3791193A (es)
CA (1) CA2131553C (es)
DE (1) DE69331987T2 (es)
DK (1) DK0627914T3 (es)
ES (1) ES2176200T3 (es)
WO (1) WO1993017675A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229423A (en) * 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent
US20020061864A1 (en) * 1994-09-22 2002-05-23 Geda International Marketing Company Ltd. Antiseptic spermicidal composition and means for its application
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
US9662360B2 (en) 2008-10-09 2017-05-30 Meritus Corporation Treatment of herpes, pseudomonas, staph, and hepatitis
DE19606355A1 (de) * 1996-02-12 1997-08-14 Schering Ag Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung
US6011013A (en) * 1997-06-20 2000-01-04 Oregon Health Sciences University Contraceptive compositions and methods
US6432941B1 (en) 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
US6051603A (en) 1998-01-20 2000-04-18 Wayne Hughes Institute Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
US6245808B1 (en) 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6485972B1 (en) 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
CN100342917C (zh) * 2002-08-20 2007-10-17 Alda医药公司 一种广谱消毒剂
US20050272819A1 (en) * 2003-07-31 2005-12-08 Arye Rubinstein Use of alkylureas for treating acne
US20050271643A1 (en) * 2003-08-14 2005-12-08 Iryna Sorokulova Bacterial strains, compositions including same and probiotic use thereof
US20110212933A1 (en) * 2008-03-20 2011-09-01 Allan Shapiro Antiseptic Compositions for the Treatment of Infections
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
WO2018208826A1 (en) * 2017-05-08 2018-11-15 Meharry Medical College Hydroxyurea to enhance sperm cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813695A (en) * 1973-02-21 1974-06-04 D Podell Surgical glove
US4482577A (en) * 1980-12-16 1984-11-13 Albert Goldstein Coating process of elastomeric material
US4499154A (en) * 1982-09-03 1985-02-12 Howard L. Podell Dipped rubber article
ES2029831T3 (es) * 1986-03-12 1992-10-01 Euroceltique Sa Un procedimiento para la preparacion de una composicion contraceptiva para aplicacion a la vagina de un mamifero hembra.
FR2598916B1 (fr) * 1986-05-22 1988-09-09 Atlantic Pharma Prod Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
US4880836A (en) * 1988-03-11 1989-11-14 Danek Elbaum Antiviral amphiphilics
US5229423A (en) * 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent

Also Published As

Publication number Publication date
AU3791193A (en) 1993-10-05
ATE218332T1 (de) 2002-06-15
CA2131553A1 (en) 1993-09-16
DE69331987T2 (de) 2003-01-16
DE69331987D1 (de) 2002-07-11
EP0627914A1 (en) 1994-12-14
US5229423A (en) 1993-07-20
EP0627914A4 (en) 1997-01-29
WO1993017675A1 (en) 1993-09-16
EP0627914B1 (en) 2002-06-05
US5387611A (en) 1995-02-07
DK0627914T3 (da) 2002-09-23
JPH08502239A (ja) 1996-03-12
CA2131553C (en) 2003-07-08

Similar Documents

Publication Publication Date Title
ES2176200T3 (es) Uso de la butirulea como agente anticonceptivo.
DE50014447D1 (de) Tablettierung verdickender systeme
BR0309769A (pt) Composições lubrificantes de aquecimento e não-irritantes e método de comparação de irritação
AR001363A1 (es) Barras de detergente sintético.
ES2145115T3 (es) Composiciones inyectables a base de derivados de taxanos.
ES2161220T3 (es) 9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos.
DE69917066D1 (de) Zusammensetzungen und methoden zur verbesserung von sexuellen funktionsstörungen bei frauen
ES2126966T3 (es) Proceso para la impregnacion hidrofuga de yeso.
HUP0100446A2 (hu) Dibenzilidén-szorbitot vagy annak származékát tartalmazó vízmentes gélkompozíciók és ilyen kompozíciókat magukban foglaló izzadásgátló kozmetikai készítmények
EA199901013A1 (ru) Гели пролонгированного действия
BRPI0417791A (pt) composição substancialmente anidra
HUP9701611A2 (hu) Nagy elektrolittartalmú V/O emulzió, alkalmazása bőrkozmetikai készítményekben, különösen irritáció és/vagy érzékeny bőr kezelésére
ES2194197T3 (es) Composicion acondicionadora de tejidos.
ES2181824T3 (es) Profarmacos de derivados de paclitaxel.
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
ES2190429T3 (es) Benciliden-quinuclidinonas como agentes protectores contra el sol.
SE9801494D0 (sv) Novel use
BR9916620A (pt) Derivados de fenetil-5-bromopiridiltiouréia (pbt) e diidroalcoxibenziloxopirimidina (dabo) exibindo atividade espermicida
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
ES2136064T3 (es) Vacunas de toxoide de pasteurella multocida.
DK1073447T3 (da) N1-modificerede glycopeptider
PE15196A1 (es) Compuesto de di-tert-butifenol util como agente antiinflamatorio
DE69424793D1 (de) Empfängnisverhütende zusammensetzungen
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.